Lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice

CNS Neuroscience and Therapeutics

Volumn 16, Issue 2, 2010, Pages 103-114

  Ito, Yasushi ^a   Nakamura, Shinsuke ^a   Tanaka, Hirotaka ^a   Tsuruma, Kazuhiro ^a   Shimazawa, Masamitsu ^a   Araie, Makoto ^b   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Glaucoma; Lateral geniculate nucleus; Lomerizine; N methyl d aspartate; Superior colliculus

Indexed keywords

LOMERIZINE; N METHYL DEXTRO ASPARTIC ACID; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN C FOS; CALCIUM CHANNEL BLOCKING AGENT; ENOLASE; N METHYLASPARTIC ACID; PIPERAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; EYE PROTECTION; LATERAL GENICULATE NUCLEUS; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RETINA INJURY; SUPERIOR COLLICULUS; VISION; VITREOUS BODY; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GENICULATE BODY; METABOLISM; NERVE DEGENERATION; NONPARAMETRIC TEST; PATHOLOGY; RETINA DISEASE; RETINA GANGLION CELL; TIME; VISUAL SYSTEM;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; GENICULATE BODIES; MALE; MICE; MICE, INBRED C57BL; N-METHYLASPARTATE; NERVE DEGENERATION; PHOSPHOPYRUVATE HYDRATASE; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-FOS; RETINAL DISEASES; RETINAL GANGLION CELLS; STATISTICS, NONPARAMETRIC; SUPERIOR COLLICULI; TIME FACTORS; VISUAL PATHWAYS;

EID: 77749289861     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2009.00081.x     Document Type: Article

References (53)

1. Hara H, Morita T, Sukamoto T, Cutrer FM. Lomerizine (KB-2796), a new antimigraine drug. CNS Drug Rev 1995 1 : 204 226.
2. 2+ channel blocker as an anti-glaucoma drug: Effects on ocular circulation and retinal neuronal damage. Cardiovasc Drug Rev 2004 22 : 199 214.
3. Kanazawa T, Nakasu Y, Masuda M, Handa J. Acute effect of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)-piperazine dihydrochloride, KB-2796, on the cerebral blood flow in unanesthetized cats. Arch Jpn Chir 1986 55 : 682 688.
4. Fechtner R, Weinreb RN. Mechanism of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol 1994 39 : 23 42.
5. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol 1994 38 : S3 S6.
6. Martinez A, Sanchez M. Ocular blood flow and glaucoma. Br J Ophthalmol 2008 1301 : 1301 1302.
7. Yücel YH, Gupta N. Paying attention to the cerebrovascular system in glaucoma. Can J Ophthalmol 2008 43 : 342 346.
8. Flammer J, Orgül S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res 1998 17 : 267 289.
9. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002 21 : 359 393.
10. 2+ antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989 227 : 408 412.
11. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993 115 : 608 613. (Pubitemid 23137645)
12. Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology 1996 103 : 283 288.
13. Karim Z, Sawada A, Kawakami H, Yamamoto T, Taniguchi T. A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat. Curr Eye Res 2006 31 : 273 283.
14. Takahashi K, Lam TT, Edward DP, Buchi ER, Tso MO. Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol 1992 110 : 862 870.
15. 2+ channel blockers on directional selectivity of rabbit retinal ganglion cells. J Neurophysiol 1995 74 : 12 23.
16. Adachi K, Kashii S, Masai H, et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol 1998 236 : 766 774.
17. Gaspar AZ, Flammer J, Hendrickson P. Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases. Eur J Ophthalmol 1994 4 : 24 28.
18. Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma 1999 8 : 117 123.
19. 2+ channel blocker, on the microcirculation in the optic nerve head in conscious rabbits: A study using a laser speckle technique. Exp Eye Res 1999 69 : 185 193.
20. 2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res 2000 70 : 475 484.
21. Gupta N, Ang LC, Noel-de TL, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006 90 : 674 678.
22. Vrabec JP, Levin LA. The neurobiology of cell death in glaucoma. Eye 2007 21 : S11 S14.
23. Yoneda S, Tanihara H, Kido N, Honda Y, Goto W, Hara H, Miyawaki N. Interleukin-1beta mediates ischemic injury in the rat retina. Exp Eye Res 2001 73 : 661 667.
24. Mooney SM, Miller MW. Postnatal generation of neurons in the ventrobasal nucleus of the rat thalamus. J Neurosci 2007 27 : 5023 5032.
25. Ito Y, Nakamura S, Tanaka H, Shimazawa M, Araie M, Hara H. Memantine protects against secondary neuronal degeneration in lateral geniculate nucleus and superior colliculus after retinal damage in mice. CNS Neurosci Ther 2008 14 : 192 202.
26. Yücel YH, Gupta N, Zhang Q, Mizisin AP, Kalichman MW, Weinreb RN. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol 2006 124 : 217 225.
27. Jones EG, Tighilet B, Tran BV, Huntsman MM. Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus. J Comp Neurol 1998 397 : 371 393.
28. Jaubert-Miazza L, Green E, Lo FS, Bui K, Mills J, Guido W. Structural and functional composition of the developing retinogeniculate pathway in the mouse. Vis Neurosci 2005 22 : 661 676.
29. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994 330 : 613 622.
30. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997 37 : 3483 3493.
31. 2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures. Jpn J Pharmacol 1993 61 : 361 365.
32. Hara H, Ozaki A, Yoshidomi M, Sukamoto T. Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia. Arch Int Pharmacodyn Ther 1990 304 : 206 218.
33. Yamada H, Chen YN, Aihara M, Araie M. Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia. Brain Res 2006 1071 : 75 80.
34. Kawashima T, Awata N, Satomi O, et al. Absorption, distribution and excretion of 1-[Bis (4-fluorophenyl) methyl]-4 (2, 3, 4-trimethoxybenzyl) piperazine dihydrochloride (KB-2796) after single oral administration in rats. Drug Metab Pharmacokinet 1990 5 : 723 737.
35. Yamashita A, Ozaki A, Ikegami A, Hayashi A, Hara H, Sukamoto T, Ito K. Effects of a new diphenylpiperazine calcium antagonist, KB-2796, on cerebral ischemic neuronal damage in rats. Gen Pharmacol 1993 24 : 1473 1480.
36. Oelschläger HH, Nakamura M, Herzog M, Burda H. Visual system labeled by c-Fos immunohistochemistry after light exposure in the 'blind' subterranean zambian mole-rat (Cryptomys anselli). Brain Behav Evol 2000 55 : 209 220.
37. Lima AG, Britto LR, Hossokawa NM, Hamassaki-Britto DE. Static, but not optokinetic visual stimuli induce Fos expression in the retina and brain of retinal degeneration mice. Neurosci Lett 2003 342 : 9 12.
38. Ito Y, Shimazawa M, Inokuchi Y, Fukumitsu H, Furukawa S, Araie M, Hara H. Degenerative alterations in the visual pathway after NMDA-induced retinal damage in mice. Brain Res 2008 1212 : 89 101.
39. Young YM, Kim YJ, Lee U. Expression of mRNAs for BDNF and NT-3 in Reactive Astrocytes. J Korean Neurosurg 2003 33 : 572 575.
40. Minckler DS, Bunt AH, Johanson GW. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 1977 16 : 426 441.
41. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma, II: The site of injury and susceptibility to damage. Arch Ophthalmol 1981 99 : 635 649.
42. Zhang L, Ino-ue M, Dong K, Yamamoto M. Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. Curr Eye Res 2000 20 : 131 136.
43. Finn JT, Weil M, Archer F, Siman R, Srinivasan A, Raff MC. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 2000 20 : 1333 1341.
44. Chan SY, Ochs S, Worth RM. The requirement for calcium ions and the effect of other ions on axoplasmic transport in mammalian nerve. J Physiol 1980 301 : 477 504.
45. Johansson JO. Influence of low IOP and low calcium on retrograde axoplasmic transport in rat optic nerve in vitro. Exp Eye Res 1985 41 : 739 744.
46. Taft WC, Clifton GL, Blair RE, DeLorenzo RJ. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res 1989 483 : 143 148.
47. Lees GJ. Inhibition of the retrograde axonal transport of dopamine-beta-hydroxylase antibodies by the calcium ionophore A23187. Brain Res 1985 345 : 62 67.
48. Gupta VK. Systemic hypertension, headache, and ocular hemodynamics: A new hypothesis. Med Gen Med 2006 8 : 63.
49. Cursiefen C, Wisse M, Cursiefen S, Jünemann A, Martus P, Korth M. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol 2000 129 : 102 104.
50. Harris A, Zarfati D, Zalish M, et al. Reduced cerebrovascular blood flow velocities and vasoreactivity in open-angle glaucoma. Am J Ophthalmol 2003 135 : 144 147.
51. Harris A, Siesky B, Zarfati D, Haine CL, Catoira Y, Sines DT, McCranor L, Garzozi HJ. Relationship of cerebral blood flow and central visual function in primary open-angle glaucoma. J Glaucoma 2007 16 : 159 163.
52. Sugiyama T, Utsunomiya K, Ota H, Ogura Y, Narabayashi I, Ikeda T. Comparative study of cerebral blood flow in patients with normal-tension glaucoma and control subjects. Am J Ophthalmol 2006 141 : 394 396.
53. Quigley HA, Sanchez RM, Dunkelberger GR, L'Hernault NL, Baginski TA. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci 1987 28 : 913 920.